The effect of melatonin on endothelial dysfunction in patients after acute coronary syndrome: The MEFACS randomized clinical trial

Keyphrases

• Acute Coronary Syndrome 100%
• Randomized Clinical Trial 100%
• Endothelial Dysfunction 100%
• Melatonin 100%
• Reactive Hyperemia Index 50%
• Missing Data 33%
• Day 14 33%
• No Significant Difference 16%
• Placebo 16%
• Placebo Groups 16%
• Comorbidity 16%
• Intention-to-treat Analysis 16%
• Uric Acid 16%
• Oxidative Stress 16%
• Uneven Distribution 16%
• Generalized Estimating Equations 16%
• Antioxidant 16%
• Arginine 16%
• Melatonin Treatment 16%
• Placebo-controlled Randomized Trial 16%
• Circadian Hormones 16%
• Asymmetric Dimethylarginine 16%
• Biomarker Concentration 16%
• Data Distribution 16%
• Marginal Mean 16%
• Differences between Groups 16%

Pharmacology, Toxicology and Pharmaceutical Science

• Acute Coronary Syndrome 100%
• Randomized Clinical Trial 100%
• Endothelial Dysfunction 100%
• Melatonin 100%
• Placebo 50%
• Hyperaemia 50%
• Biological Marker 33%
• Arginine 16%
• Randomized Controlled Trial 16%
• Uric Acid 16%
• Antioxidant 16%
• 6 N,n' Dimethylarginine 16%
• N(g),n(g) Dimethylarginine 16%
• Comorbidity 16%